Adgyl Lifesciences Private Limited, a active foreign private limited company, was established on 27 November 2018 in Bengaluru, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U74999KA2018FTC118861. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹16.00 Cr and a paid-up capital of ₹13.21 Cr.
It upholds a compliant status. Employing 241 professional, Its leadership includes Haladasappa Krishnappa (Managing Director), Girish Suhas Joshi (Additional Director), Suresh Kumar (Additional Director). Past directors included Haladasappa Krishnappa, Amith Gurpur Yeshwanth, Neeraj Rameshwar Garg. It holds ₹5.67 M open charges and ₹3.03 M settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 21 & 22, Phase Ii, Peenya Industrial Area,, Bengaluru, Karnataka, 560058.
U74999KA2018FTC118861
118861
27 November 2018
₹16.00 Cr
₹13.21 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Adgyl Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Haladasappa Krishnappa | Managing Director | 11 Jul 2023 | Current |
| Girish Suhas Joshi | Additional Director | 03 Sep 2025 | Current |
| Suresh Kumar | Additional Director | 17 Dec 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 11 Jul 2023 | Past |
| Pramod Abcsdd | Director | 25 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Aug 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 31 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 25 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adgyl Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.3% increase. The company also saw a substantial improvement in profitability, with a 41.38% increase in profit. The company's net worth moved up by a moderate rise of 9.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Adgyl Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,670,149.00
₹3,034,583.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2024 | Axis Bank Limited | ₹5.67 M | Open |
| 31 Oct 2023 | Axis Bank Limited | ₹3.03 M | Satisfied |
Explore comprehensive loan charge details -
Adgyl Lifesciences has a workforce of 241 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Adgyl Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adgyl Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 31 Oct 2023 via Charge ID 100810690 with Axis Bank Limited was fully satisfied on 26 Dec 2025. was completed.
Progress on Suresh Kumar was appointed as a Additional Director was appointed as a Additional Director on 17 Dec 2025 & has been associated with this company since 1 month 1 day . was documented.
The activity Adgyl Lifesciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
Progress on Girish Suhas Joshi was appointed as a Additional Director was appointed as a Additional Director on 03 Sep 2025 & has been associated with this company since 4 months 17 days . was documented.
Adgyl Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 0.57 Cr with Charge ID 100899518 was registered on 27 Mar 2024. was completed.
The CIN of Adgyl Lifesciences Private Limited is U74999KA2018FTC118861.
Adgyl Lifesciences Private Limited is headquartered at 21 & 22, Phase Ii, Peenya Industrial Area,, Bengaluru, Karnataka, 560058.
Adgyl Lifesciences Private Limited was incorporated on 27 November 2018.
The current directors of Adgyl Lifesciences Private Limited are
The primary industry of Adgyl Lifesciences Private Limited is Professional, Scientific And Technical.
Adgyl Lifesciences Private Limited is unlisted.
The authorized capital of Adgyl Lifesciences Private Limited is ₹16.00 Cr, and the paid-up capital is ₹13.21 Cr.
The compliance status of Adgyl Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX